Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2002
11/28/2002US20020176847 Administering to a mammal viral vectors for treating and preventing atherosclerosis, osteoporosis, cardiovascular disease, Alzheimer's disease, diabetes mellitus, infectious diseases, cancer, and inherited disorders
11/28/2002DE10125763A1 New use of indirubin derivatives as VEGF inhibitors useful for preparing medicaments useful for e.g. treating cancer, autoimmune diseases, cardiovascular diseases or viral infections
11/28/2002DE10125145A1 New C-furanyl- or C-thienyl-methylamine derivatives, useful e.g. for treating arrhythmia, emesis, inflammation, cardiovascular or neurodegenerative disease, asthma, glaucoma or especially pain
11/28/2002DE10123958A1 Identifying ligands for G protein-coupled receptors, useful for treating cardiovascular disease, by using calcium-sensitive fluorophores in cells expressing G alpha proteins
11/28/2002DE10123586A1 New 3,5-diamino-1,2,4-triazole derivatives, are cyclin dependent kinase inhibitors useful for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections
11/28/2002CA2450535A1 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
11/28/2002CA2449442A1 Combination medicament for treatment of neoplastic diseases
11/28/2002CA2448449A1 Treatment of renal fibrosis
11/28/2002CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002CA2448045A1 Identifying parasitic fungi of the organism, and treatment thereof
11/28/2002CA2448022A1 Compositions for protein delivery via the pulmonary route
11/28/2002CA2447958A1 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002CA2447716A1 Preventive or remedy for diseases caused by cerebrovascular disturbances
11/28/2002CA2447598A1 Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
11/28/2002CA2447340A1 Kinases and phosphatases
11/28/2002CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002CA2447023A1 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002CA2447020A1 The use of 4-aminopyridine derivatives for the treatment of mglur5 receptor mediated diseases
11/28/2002CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002CA2446331A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446313A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446155A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002CA2446154A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446049A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
11/28/2002CA2445631A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002CA2444787A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
11/28/2002CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002CA2438597A1 Champ - a cardiac helicase-like factor
11/28/2002CA2427619A1 Pharmaceutically active isoindoline derivatives
11/28/2002CA2410628A1 Carbamic acid esters
11/28/2002CA2410627A1 Glycinamides
11/27/2002EP1260519A1 Membrane receptors for steroids and sterols
11/27/2002EP1260512A1 Novel cyclic amide derivatives
11/27/2002EP1260232A1 Remedies for malignant tumor-concomitant neurosis and azoor or analogous diseases thereof
11/27/2002EP1260231A1 Drugs for ameliorating retinal function
11/27/2002EP1260224A1 Sulfonyl pyridazinone compounds as therapeutic agents for ischemic tissue damage
11/27/2002EP1259626A2 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
11/27/2002EP1259621A2 Lipid metabolism enzymes
11/27/2002EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002EP1259611A2 G-protein coupled receptors
11/27/2002EP1259605A2 Mutated cyclin g1 protein
11/27/2002EP1259595A2 Integrin antagonists
11/27/2002EP1259546A1 Ccr2-64i, polymorphic variant of the human ccr2 receptor and its use in the diagnostic and treatment of atherosclerosis
11/27/2002EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002EP1259527A1 35 human secreted proteins
11/27/2002EP1259512A1 Pteridine compounds for the treatment of psoriasis
11/27/2002EP1259510A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
11/27/2002EP1259508A1 Novel biarylcarboxamides
11/27/2002EP1259506A1 Pyrazinone thrombin inhibitors
11/27/2002EP1259505A2 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
11/27/2002EP1259504A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
11/27/2002EP1259499A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors
11/27/2002EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002EP1259493A2 Substituted piperazine compounds
11/27/2002EP1259489A1 Aryl fused azapolycyclic compounds
11/27/2002EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002EP1259484A1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion
11/27/2002EP1259481A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
11/27/2002EP1259477A1 Aminoadamantane derivatives as therapeutic agents
11/27/2002EP1259474A1 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
11/27/2002EP1259292A2 Therapeutic agents
11/27/2002EP1259262A1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/27/2002EP1259248A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d
11/27/2002EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002EP1259235A1 Tyrosine kinase inhibitors
11/27/2002EP1259234A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
11/27/2002EP1259230A2 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
11/27/2002EP1259194A1 Bulbous valve and stent for treating vascular reflux
11/27/2002EP1192152B1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
11/27/2002EP1112005B1 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid
11/27/2002EP1107795B1 Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
11/27/2002EP1073639B1 Quinoline derivatives
11/27/2002EP1017672B1 New npy antagonists
11/27/2002EP1000048B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
11/27/2002EP1000035B1 Substituted 6-phenylphenanthridines
11/27/2002EP0934331B1 Mirror-symmetrical selection and evolution of nucleic acids
11/27/2002EP0920330B1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
11/27/2002EP0783303B1 Use of aromatic halides for treating mammalian cell proliferation
11/27/2002EP0777471B1 Inhibition of leukotriene biosynthesis with urea derivatives
11/27/2002EP0708648B1 Inhibition of nitric oxide production by retinoic acid
11/27/2002EP0585267B1 Herpesvirus particle preparation and vaccine
11/27/2002CN1382211A Treatment of inflammatory or malignant disease using dnazymes
11/27/2002CN1382151A Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols
11/27/2002CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002CN1382142A Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382138A Piperidine derivatives as reuptake inhibitors
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382134A Benzopyranyl guanidine derivtives, process for preparation thereof and pharmaceutical compositions containing them
11/27/2002CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002CN1382121A C16 unsaturated FP-selective prostaglandins analogs
11/27/2002CN1382120A Method of producing n-(4,5-bis-(methanesulfonyl)-2-methyl-benzoyl)-guanidine, hydrochloride thereof
11/27/2002CN1382119A Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof
11/27/2002CN1382118A Biocyclic amino acids aspharmaceutical agents
11/27/2002CN1382053A Novel hormonal composition and use thereof
11/27/2002CN1382052A Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
11/27/2002CN1382022A Method for treatment of chronic venous insufficiencies using extract of red vine leaves
11/27/2002CN1381460A Structure and usage of plasminogen activator (TPA) mutant
11/27/2002CN1381459A Deacidified gingko leaf and its extract and its preparing process and application
1 ... 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 ... 1595